Q1 2021 Talis Biomedical Corp Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Talis First Quarter 2021 Earnings Conference Call. (Operator Instructions)
Without further ado, I would like to welcome your first speaker for today, Ms. Emily Faucette from SVP Corporate Communications and Investor Relations. Ma'am, the floor is yours.
Good afternoon, and thank you for participating in today's conference call. Joining me, we have Brian Coe, our Chief Executive Officer; and Roger Moody, our Chief Financial Officer.
Earlier today, Talis released financial results and business progress for the quarter ended March 31, 2021. A copy of that press release can be accessed on the Investors page of our website at talisbio.com.
Before we get started, I would like to remind you that management will make statements during this call that are forward-looking statements within the meaning of the federal securities laws. These statements involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |